Home > Financial Ratios > GLAND PHARMA
COMMUNITY POLL
for GLAND PHARMA
Please provide your vote to see the results

GLAND PHARMA Last 5 Year EBIT Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EBIT Growth(%) -4.679.11-34.6021.3433.82

What is the latest EBIT Growth ratio of GLAND PHARMA ?

The latest EBIT Growth ratio of GLAND PHARMA is -4.67 based on Mar2025 Consolidated results.
Year EBIT Growth
Mar2025-4.67
Mar20249.11
Mar2023-34.60
Mar202221.34
Mar202133.82

How is EBIT Growth of GLAND PHARMA Trending?

Years EBIT Growth % Change
Mar2025 -4.67
Negative
Mar2024 9.11
Positive
Mar2023 -34.6
Negative
Mar2022 21.34
-36.90
Mar2021 33.82 -

Other Financial Ratios of GLAND PHARMA


Compare EBIT Growth ratio of peers of GLAND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAND PHARMA ₹31,232.1 Cr -0.5% 10.1% 29.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹447,032.0 Cr 0.9% 12.8% 4.6% Stock Analytics
DIVIS LABORATORIES ₹183,759.0 Cr 3.2% 14% 13.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹149,224.0 Cr 0.7% 5.5% 36.9% Stock Analytics
CIPLA ₹116,214.0 Cr 6.8% 18.8% -10.2% Stock Analytics
DR REDDYS LABORATORIES ₹108,739.0 Cr 0.7% 5.5% 9.4% Stock Analytics


GLAND PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLAND PHARMA

-0.5%

10.1%

29.3%

SENSEX

-3.1%

-2.8%

-6.1%


You may also like the below Video Courses